MedTrace Logo

Changes in the Urinary Microbiome and Metabolome During Treatment of the Overactive Bladder in Female Patients

NCT06921746 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-05-04

No results posted yet for this study

Summary

This is a non-interventional study that will not pose any burden for the participants. The study subjects will be examined and treated in a standard manner according to current clinical recommendations for the treatment of overactive bladder (OAB). A portion of urine samples, which are routinely collected for biochemical and culture examinations as part of the diagnostic process, will be sent for examination of the characteristics of the urinary microbiome and metabolome (UMM) before and after treatment.

Conditions

Interventions

DIAGNOSTIC_TEST

Urine Microbiological and Metabolomic Analysis

Microbiological and metabolomic analysis of a urine sample will be performed in the study subjects, before and after the end of the treatment.

Sponsors & Collaborators

  • University Hospital Bulovka

    collaborator UNKNOWN

  • Thomayer University Hospital

    collaborator OTHER

  • Institute of Microbiology of the Czech Academy of Sciences

    collaborator UNKNOWN

  • University Hospital Ostrava

    lead OTHER

Principal Investigators

  • Jan Krhut, prof., MD, PhD · University Hospital Ostrava

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06921746 on ClinicalTrials.gov